QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.102.047191v1 306/1/324    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ramakrishnan, R. Articles by Jusko, W. J. Search for Related Content PubMed PubMed Citation Articles by Ramakrishnan, R. Articles by Jusko, W. J.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin after Intravenous and Subcutaneous Dose Administration in Cynomolgus Monkeys

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (R.R., W.J.J.); and R.W. Johnson Pharmaceutical Research Institute, Raritan, New jersey (W.K.C., F.F., L.J.)

The pharmacokinetics (PK) and pharmacodynamics (PD) of recombinant human erythropoietin (rHuEpo) were investigated in monkeys. A two-compartment model with dual input and nonlinear disposition could adequately characterize the PK of rHuEpo upon three intravenous and six s.c. administrations. The kinetic model suggests rapid zero-order absorption of part of the s.c. dose (35%) followed by a slow first-order entry through the lymphatics. The s.c. treatments caused a delayed dose-dependent rise in reticulocyte numbers peaking between 100 and 200 h and returning to baseline by 300 to 400 h. This was followed by steady rises in red blood cell (RBC) and hemoglobin counts. A physiological catenary model based on a life span concept with rHuEpo stimulating the production of two cell populations (progenitor cells and erythroblasts) was applied. The model could adequately describe the reticulocyte responses upon the various s.c. treatments, giving estimates of maturation times for cells in the various stages of differentiation including the early progenitor cells (70.4 h), erythroblasts (15.0 h), and reticulocytes (141.6 h) that are close to the literature reported values. An S_max of 3.13 was estimated indicating a moderate maximum stimulation of erythropoiesis, whereas the SC₅₀ was 842 IU/l. The model was used to effectively predict the increases in RBC and hemoglobin counts as well. In conclusion, the physiological PK/PD model developed could adequately describe the time course of rHuEpo effects, yielding realistic estimates of cell life span parameters.

Address correspondence to: Dr. William J. Jusko, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, 565 Hoch-stetter Hall, State University of New York at Buffalo, Buffalo NY 14260. E.mail: wjjusko{at}buffalo.edu

This article has been cited by other articles:

				A. K. Abraham, D. E. Mager, X. Gao, M. Li, D. R. Healy, and T. S. Maurer Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Parathyroid Hormone-Calcium Homeostasis in Rats and Humans J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 169 - 178. [Abstract] [Full Text] [PDF]

				S. Woo and W. J. Jusko Interspecies Comparisons of Pharmacokinetics and Pharmacodynamics of Recombinant Human Erythropoietin Drug Metab. Dispos., September 1, 2007; 35(9): 1672 - 1678. [Abstract] [Full Text] [PDF]

				S. Woo, W. Krzyzanski, and W. J. Jusko Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin after Intravenous and Subcutaneous Administration in Rats J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1297 - 1306. [Abstract] [Full Text] [PDF]

				D. N. McLennan, C. J. H. Porter, G. A. Edwards, S. W. Martin, A. C. Heatherington, and S. A. Charman Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 345 - 351. [Abstract] [Full Text] [PDF]